PMID: 5299130Mar 1, 1967Paper

Participation of neural factor in the pathogenesis of hypertension in the spontaneously hypertensive rat

Japanese Heart Journal
K OkamotoM Matsumoto

Abstract

No abstract listed.

Citations

Sep 1, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·K Nakamura, K Nakamura
Dec 1, 1993·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Z Zukowska-GrojecA K Myers
Dec 1, 1993·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·C A Jackson, P A Insel
May 29, 2012·Current Hypertension Reports·Francine Z Marques, Brian J Morris
Jan 1, 1978·European Journal of Pharmacology·K O'DeaA J Marino
Oct 15, 1978·European Journal of Pharmacology·J C JuskevichD Whitehorn
Jan 1, 1988·Physiology & Behavior·M M Myers, F M Scalzo
Jan 1, 1983·Neuroscience and Biobehavioral Reviews·R McCarty
Feb 1, 1996·Brain Research. Molecular Brain Research·T KumaiS Kobayashi
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M Naruse, T Inagami
Feb 1, 1988·Clinical and Experimental Pharmacology & Physiology·B JarrottA Shulkes
Feb 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A H FarajG B Lindop
Sep 1, 1978·The Journal of Clinical Investigation·K Takeda, R D Buñag
Jul 1, 1983·The International Journal of Neuroscience·J S Richardson, E K Chiu
Jan 1, 1988·Clinical and Experimental Hypertension. Part A, Theory and Practice·R TabeiM Terada
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·Z Zukowska-GrojecG Feuerstein
Jan 1, 1983·Clinical and Experimental Hypertension. Part A, Theory and Practice·T Kubo, C Su
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·E E Soltis, F P Field
Jan 1, 1978·Clinical and Experimental Hypertension : CHE·A P Provoost, W De Jong
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·A T Hamed, M F Lokhandwala
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·T T ZsotérS Sirko
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·G M Walsh, A J Tobia
Feb 1, 1980·Clinical and Experimental Hypertension : CHE·N D VlachakisR F Maronde
Jul 1, 1990·Journal of Neuroscience Research·J D LevineA I Basbaum
Mar 1, 1976·Progress in Cardiovascular Diseases·M J Brody, B G Zimmerman
Jan 11, 1975·American Heart Journal·T G ColemanJ DeClue

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.